Longeveron LLC (LGVN)

Currency in USD
0.744
-0.011(-1.43%)
Real-time Data·
LGVN Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
LGVN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.7400.780
52 wk Range
0.6332.860
Key Statistics
Prev. Close
0.755
Open
0.78
Day's Range
0.74-0.78
52 wk Range
0.633-2.86
Volume
461.24K
Average Volume (3m)
879.33K
1-Year Change
-71.07%
Book Value / Share
1.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
LGVN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
8.888
Upside
+1,094.56%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Longeveron LLC News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Longeveron LLC Company Profile

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 1 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer’s disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.

Longeveron LLC Earnings Call Summary for Q2/2025

  • Longeveron's stock surged 25.89% after Q2 earnings, despite 31% revenue drop to $700,000 and widened net loss of $10 million
  • Company raised $5 million through public offering, focusing on stem cell therapy and pipeline expansion
  • Planned BLA filing for HLHS in late 2026 and phase two trial for pediatric dilated cardiomyopathy in 2026, estimated at $15-20 million
  • CEO highlighted potential of stem cell technology, with pivotal HLHS data expected and first BLA filing next year
  • Analysts' price targets range $6-$10, despite stock being down 67.7% over past year, per InvestingPro data
Last Updated: 13/08/2025, 22:40
Read Full Transcript

Compare LGVN to Peers and Sector

Metrics to compare
LGVN
Peers
Sector
Relationship
P/E Ratio
−0.6x−4.0x−0.5x
PEG Ratio
−0.01−0.100.00
Price/Book
1.2x1.2x2.6x
Price / LTM Sales
7.5x7.8x3.3x
Upside (Analyst Target)
-314.0%40.6%
Fair Value Upside
Unlock5.1%5.3%Unlock

Analyst Ratings

3 Buy
0 Hold
0 Sell
Ratings:
3 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 8.888
(+1,094.56% Upside)

Earnings

Latest Release
May 08, 2025
EPS / Forecast
-0.34 / -0.21
Revenue / Forecast
381.00K / --
EPS Revisions
Last 90 days

LGVN Income Statement

People Also Watch

21.73
SRPT
+7.02%
2.110
VOR
+6.57%
0.791
GAME
-11.14%
2.53
INMB
+3.26%
1.3850
TNON
-1.07%

FAQ

What Stock Exchange Does Longeveron LLC Trade On?

Longeveron LLC is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Longeveron LLC?

The stock symbol for Longeveron LLC is "LGVN."

What Is the Longeveron LLC Market Cap?

As of today, Longeveron LLC market cap is 15.47M.

What Is Longeveron LLC's Earnings Per Share (TTM)?

The Longeveron LLC EPS (TTM) is -1.86.

From a Technical Analysis Perspective, Is LGVN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Longeveron LLC Stock Split?

Longeveron LLC has split 1 times.

How Many Employees Does Longeveron LLC Have?

Longeveron LLC has 25 employees.

What is the current trading status of Longeveron LLC (LGVN)?

As of 15 Aug 2025, Longeveron LLC (LGVN) is trading at a price of 0.74, with a previous close of 0.76. The stock has fluctuated within a day range of 0.74 to 0.78, while its 52-week range spans from 0.63 to 2.86.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.